VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and...

A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for...

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3...

New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods for more effective...

Despite significant advancements in cancer treatment, drug resistance remains a persistent challenge. Cancer cells can often develop resistance to...

Glaucoma drug methazolamide shows potential in fighting neurodegenerative diseases, offering new hope for treating conditions like Alzheimer's and...

WEDNESDAY, Oct. 30, 2024 -- Atrasentan is associated with a significant and clinically meaningful reduction in proteinuria compared with placebo in...

A team of scientists has uncovered a mechanism by which ovarian cancer tumors evade immunotherapy. They've also pinpointed a potential drug target...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual...